Literature DB >> 12048913

Evaluation of inflammatory-response-induced thoracoscopic surgical stress.

Tomoharu Kuda1, Yoshihiko Kamada, Naoji Nagamine, Jun Oshiro, Masayuki Kuniyoshi, Keiichiro Genka, Kageharu Koja.   

Abstract

OBJECTIVE: Due to the paucity of reports evaluating stress induced by thoracoscopic surgery with minithoracotomy, we assessed this stress based on the inflammatory response to surgery.
METHODS: Differences in pre- and postoperative peripheral white blood cell (WBC) count, serum C-reactive protein (CRP), and serum interleukin-6 (IL-6) were evaluated, defined as dW, dCRP, and dIL-6. Thoracoscopic partial lung resection cases were divided into 2 groups by access route: Group A patients in which surgery was concluded via several small access ports. and Group B patients going surgery via small access ports plus minithoracotomy. We also compared dW in standard lobectomy with exploratory thoracotomy (thoracotomy without lobectomy) cases.
RESULTS: No significant difference was seen in dW, dCRP, or dIL-6 between groups. dW in response to exploratory thoracotomy was lower than that in standard lobectomy (p = 0.06).
CONCLUSIONS: Surgical stress induced by thoracoscopic partial lung resection does not increase significantly when minithoracotomy is added. Postoperative inflammatory response may, however, be influenced by the extent of surgical trauma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048913     DOI: 10.1007/bf03032287

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  2 in total

1.  Minimal increase in serum interleukin-6 levels during laparoscopic cholecystectomy.

Authors:  H Ueo; M Honda; M Adachi; H Inoue; H Nakashima; S Arinaga; T Akiyoshi
Journal:  Am J Surg       Date:  1994-10       Impact factor: 2.565

2.  Production of interleukin-6 at operative wound sites in surgical patients.

Authors:  H Ueo; H Inoue; M Honda; I Uchida; M Nishimura; S Arinaga; H Nakashima; T Akiyoshi
Journal:  J Am Coll Surg       Date:  1994-09       Impact factor: 6.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.